GlaxoSmithKline up 4% after failed $68B Unilever bid for consumer health unit
GlaxoSmithKline up 4% after failed $68B Unilever bid for consumer health unit
MarketWatch
0 shares
1 views
You might like
Related news coverage
Consumer goods giant Unilever cutting 1,500 management jobs
SeattlePI.com
LONDON (AP) — Unilever, which makes Vaseline skin care products and Ben & Jerry’s ice cream, says it's laying off 1,500 staff..
Advertisement
More coverage
Unilever backs down on raising £50bn bid for GSK consumer health arm
City A.M.
Unilever has announced it will not raise its £50bn bid for GlaxoSmithKline's consumer health arm after the pharma giant rebuffed..
-
GlaxoSmithKline drops on report that Unilever won't increase bid for consumer unit above GBP50B
SeekingAlpha
-
Unilever’s bid for consumer unit unlikely to generate upside for GlaxoSmithKline - BofA
SeekingAlpha
-
The challenge to GSK from Unilever’s blockbuster consumer bid
FT.com
-
Unilever sees investor backlash over $68B bid for GlaxoSmithKline consumer unit
SeekingAlpha